TEL AVIV, Israel, May 6, 2024 /PRNewswire/ -- BioLineRx Ltd. (BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results